Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Radiopharmaceutical conjugate of a metabolite and an EPR agent, for targeting tumour cells

US Patent 10874753 · Granted Dec 29, 2020

Assignee

Inventors

View full patent text on Google Patents →